A detailed history of Creative Financial Designs Inc transactions in Repligen Corp stock. As of the latest transaction made, Creative Financial Designs Inc holds 100 shares of RGEN stock, worth $12,606. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$12,606
Previous $17,000 5.88%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$138.78 - $176.51 $4,857 - $6,177
-35 Reduced 25.93%
100 $15,000
Q1 2023

Apr 25, 2023

BUY
$154.26 - $198.1 $5,399 - $6,933
35 Added 35.0%
135 $22,000
Q3 2021

Oct 08, 2021

SELL
$194.77 - $324.21 $9,738 - $16,210
-50 Reduced 33.33%
100 $29,000
Q2 2021

Jul 27, 2021

BUY
$165.87 - $220.95 $8,293 - $11,047
50 Added 50.0%
150 $30,000
Q4 2020

Jan 08, 2021

BUY
$148.08 - $206.57 $14,808 - $20,657
100 New
100 $19,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Creative Financial Designs Inc Portfolio

Follow Creative Financial Designs Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

News

Stay updated on Creative Financial Designs Inc with notifications on news.